Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder.

NCT00611026 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2417

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: Tolterodine ER
DRUG: Placebo
DRUG: Fesoterodine

Sponsor

Pfizer